Clinical Trial Update: Bioavailability Food-Effect Study of an Oral Nitisinone Formulation to Treat Hereditary Tyrosinemia (HT-1) [Phase 1]

View source ↗

Summary

Phase 1 bioavailability/food-effect study of an oral nitisinone formulation for Hereditary Tyrosinemia Type I completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Tyrosinemia Type

Drugs mentioned

• Nitisinone (Nitisinone)

Snippet

Sponsor: Cycle Pharmaceuticals Ltd. | Conditions: Hereditary Tyrosinemia, Type I | Phase 1 | Status: COMPLETED | Results posted: 2016-12-13